Sign Up to like & get
recommendations!
1
Published in 2022 at "Drug Design, Development and Therapy"
DOI: 10.2147/dddt.s356988
Abstract: Introduction Epidermal growth factor receptor (EGFR) regulates several cell functions which include cell growth, survival, multiplication, differentiation, and apoptosis. Currently, EGFR kinase inhibitors are of increasing interest as promising targeted antitumor therapeutic agents. Methods Different…
read more here.
Keywords:
molecular docking;
cell;
thiazolyl pyrazolines;
thiazol one ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22168609
Abstract: A common mechanism in which glucocorticoids participate is suggested in the pathogenesis of such metabolic diseases as obesity, metabolic syndrome, or Cushing’s syndrome. The enzyme involved in the control of the availability of cortisol, the…
read more here.
Keywords:
ylamino thiazol;
thiazol one;
novel adamantan;
adamantan ylamino ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24087252
Abstract: In this study, a series of nine new 2-(cyclopentylamino)thiazol-4(5H)-one derivatives were synthesized, and their anticancer, antioxidant, and 11β-hydroxysteroid dehydrogenase (11β-HSD) inhibitory activities were tested. Anticancer activity has been assessed using the MTS (MTS: 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay…
read more here.
Keywords:
cyclopentylamino thiazol;
inhibitory;
thiazol one;
one derivatives ... See more keywords